NCT04899063 (ELTGTS) is a NA clinical trial of ELIOS Procedure in Glaucoma, Primary Open Angle, sponsored by Elios Vision, Inc..

Who is sponsoring NCT04899063?

NCT04899063 is sponsored by Elios Vision, Inc..

What drugs are being tested in NCT04899063?

Interventions in NCT04899063: ELIOS Procedure.

What condition does NCT04899063 study?

NCT04899063 studies Glaucoma, Primary Open Angle.

Is NCT04899063 still recruiting?

NCT04899063 is currently completed. Last updated 30 September 2025.

Last reviewed 2025-09-30 · How we verify

NCT04899063: ELTGTS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Excimer Laser Trabeculostomy Glaucoma Treatment Study

Completed NA Last updated 30 September 2025

What this trial tests

NA trial testing ELIOS Procedure in Glaucoma, Primary Open Angle in 318 participants. Completed in 29 July 2025.

Timeline

10 May 2021

Primary endpoint
29 July 2025

29 July 2025

Quick facts

Lead sponsor	Elios Vision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	318
Start date	10 May 2021
Primary completion	29 July 2025
Estimated completion	29 July 2025
Sites	20 locations across United States

Drugs / interventions tested

ELIOS Procedure

Conditions studied

Glaucoma, Primary Open Angle — all drugs for Glaucoma, Primary Open Angle →

Sponsor

Elios Vision, Inc.

Who can join

45 and older, any sex, with Glaucoma, Primary Open Angle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG) undergoing cataract surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Glaucoma, Primary Open Angle

Currently open trials in the same condition.

NCT03675412 — Caffeine Consumption in Glaucoma Patients and Healthy Subjects · NA · recruiting
NCT05370287 — Adaptive Optics Retinal Imaging · NA · recruiting

Other Elios Vision, Inc. trials

Trials by the same sponsor.

NCT06246136 — Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04899063 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elios Vision, Inc.
Last refreshed: 30 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04899063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing